Using a human dataset and preclinical murine models of NASH, we identified an inverse correlation between ER stress-triggered CRELD2 and the de novo lipogenesis driver FASN. The gene discussed is CRELD2; the disease is metabolic dysfunction-associated steatohepatitis.